<p>Combination Antiangiogenic and Immunotherapy for Advanced Hepatocellular Carcinoma: Evidence to Date</p>-Reference-Cited by-同舟云学术

Combination Antiangiogenic and Immunotherapy for Advanced Hepatocellular Carcinoma: Evidence to Date

Published:2020-09 Issue: Volume:Volume 7 Page:133-142
ISSN:2253-5969
Container-title:Journal of Hepatocellular Carcinoma
language:en
Short-container-title:JHC

Author:

Raybould Alison L,Sanoff Hanna

Publisher

Informa UK Limited

Subject

General Medicine

Reference56 articles.

1. American Cancer Society. Key statistics about liver cancer. [Internet]. Available from: https://www.cancer.org/cancer/liver-cancer/about/what-is-key-statistics.html. Accessed April 1, 2020.

2. Cancer statistics, 2019

3. Prognosis of untreated hepatocellular carcinoma

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A quartet of cancer stem cell niches in hepatocellular carcinoma;Cytokine & Growth Factor Reviews;2024-10

2. A Case of Advanced Hepatocellular Carcinoma with Multiple Intrahepatic Metastases and Peritoneal Dissemination Treated using Atezolizumab plus Bevacizumab Combination Therapy, Resulted in Pathological Complete Response, with Concomitant Endoscopic Therapies for Early Gastric and Colorectal Cancers;Kanzo;2024-09-01

3. Camrelizumab combined with apatinib for unresectable, metastatic esophageal squamous cell carcinoma: a single-center, single-arm, prospective study;Journal of Gastrointestinal Oncology;2024-02

4. Surgery for Hepatocellular Carcinoma With Macroscopic Vascular Invasion in the Era of Modern Molecular Therapy;Anticancer Research;2023-09-29

5. Management of upper gastrointestinal bleeding in advanced hepatocellular carcinoma with portal hypertension and variceal bleeding during receiving tyrosine kinase inhibitors therapy: Beyond and known frontiers;Liver Cancer International;2023-09